Clinical Trial Update: The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the impact of Parathyroid Hormone on craniofacial osseous regeneration in implant-related outcomes was terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Implant-related Craniofacial Bone Regeneration

Drugs mentioned

• Parathyroid hormone (Parathyroid hormone)

Snippet

Sponsor: University of Michigan | Conditions: Implant | Phase 2 | Status: TERMINATED | Results posted: 2018-02-07